Rite Aid Corporation (RAD)
(Delayed Data from NYSE)
$8.77 USD
-0.03 (-0.34%)
Updated May 3, 2019 04:02 PM ET
After-Market: $8.75 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.77 USD
-0.03 (-0.34%)
Updated May 3, 2019 04:02 PM ET
After-Market: $8.75 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
The Zacks Analyst Blog Highlights: Hibbett Sports, Arcos Dorados, RH, Genesco and Rite Aid
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Hibbett Sports, Arcos Dorados, RH, Genesco and Rite Aid
Why Rite Aid (RAD) is Poised for Splendid Returns in 2020
by Zacks Equity Research
Rite Aid's (RAD) sound fundamentals and strategic endeavors might help it retain its bull run in 2020. Wellness remodels, the expansion of EnvisionRxOptions and innovative products are keys to growth.
5 Top Retail Stocks Set to Surge in 2020 After a Solid 2019
by Nalak Das
Retailers have been benefiting from their concerted endeavors in product innovation, introduction of new styles, merchandise replenishment and store refurbishments.
Implied Volatility Surging for Rite Aid (RAD) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Rite Aid (RAD) stock based on the movements in the options market lately.
5 Must-Buy Small-Cap Stocks for a Steady Rally in 2020
by Sweta Jaiswal, FRM
A trade deal with high prospects, low interest rate environment and the rising US economy make the investment scenario look attractive for 2020.
Will Rite Aid Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Rite Aid.
New Strong Buy Stocks for December 26th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
Rite Aid (RAD) in Focus: Stock Moves 7% Higher
by Zacks Equity Research
Rite Aid (RAD) shares rose 7% in the last trading session, amid huge volumes.
Rite Aid (RAD) Earnings Surpass Estimates in Q3, Stock Up
by Zacks Equity Research
Rite Aid (RAD) posts robust results in third-quarter fiscal 2020. Notably, the bottom line benefits from higher adjusted EBITDA in the quarter.
Rite Aid (RAD) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Rite Aid (RAD) delivered earnings and revenue surprises of 1700.00% and 0.64%, respectively, for the quarter ended November 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Rite Aid (RAD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rite Aid (RAD) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Rite Aid's (RAD) third-quarter fiscal 2020 results are expected to reflect progress on its growth strategy. Weak front-end same-store sales and Retail Pharmacy segment might have been drags.
Rite Aid (RAD) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Rite Aid (RAD) closed at $8.08, marking a -0.25% move from the previous day.
Rite Aid (RAD) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Rite Aid (RAD) closed the most recent trading day at $8.44, moving -1.97% from the previous trading session.
Rite Aid (RAD) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Rite Aid (RAD) closed at $9.60, marking a -0.83% move from the previous day.
Rite Aid (RAD) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Rite Aid (RAD) closed at $9.59 in the latest trading session, marking a -0.1% move from the prior day.
Rite Aid (RAD) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Rite Aid (RAD) closed the most recent trading day at $11.02, moving -0.99% from the previous trading session.
Rite Aid (RAD) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Rite Aid (RAD) closed the most recent trading day at $9.17, moving +1.21% from the previous trading session.
Rite Aid (RAD) Up 8.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Kroger, Walmart, Rite Aid, Altria and Phillip Morris
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Kroger, Walmart, Rite Aid, Altria and Phillip Morris
What's Next for Altria (MO) Stock After Kroger (KR), Walmart (WMT), and Other Retailers Abandon E-Cigarette Sales?
by Christopher Vargas
Supermarket giant Kroger (KR) became the latest retailer to discontinue the sale of electronic cigarettes amid regulatory scrutiny.
Walgreens Inks Retail Health Collaboration Deal With Novant
by Zacks Equity Research
This collaboration is in line with Walgreens' (WBA) commitment toward providing affordable and convenient healthcare facilities to residents of North Carolina.
Rite Aid (RAD) Beats Q2 Earnings Estimates, Updates View
by Zacks Equity Research
Rite Aid (RAD) posts mixed second-quarter fiscal 2020 results. Further, management revises its view for the fiscal year.
Company News For Sep 27, 2019
by Zacks Equity Research
Companies In The News Are: RAD, BYND, SCHN, CCL
Rite Aid (RAD) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Rite Aid (RAD) delivered earnings and revenue surprises of 50.00% and -0.91%, respectively, for the quarter ended August 2019. Do the numbers hold clues to what lies ahead for the stock?